Practical guide to supportive care of patients with functional neuroendocrine tumors

Lowell B Anthony1

  • 1Department of Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA. Lowell.anthony@uky.edu

Seminars in Oncology
|February 9, 2013
PubMed

Insights

Managing functional neuroendocrine tumors (NETs) involves targeted therapies and interventions to control symptoms and reduce tumor burden. Early, comprehensive care plans are crucial for optimizing patient outcomes and minimizing side effects.

Area of Science:

  • Oncology
  • Endocrinology
  • Gastroenterology

Background:

  • Supportive care for functional neuroendocrine tumors (NETs) has advanced with targeted agents and improved surgical/radiologic techniques.
  • Clinicians face challenges in recognizing symptom complexes, selecting diagnostic tests, and timing interventions for NETs.
  • Patient-specific factors like symptom severity, disease site, tumor bulk, comorbidities, and prior treatments influence management strategies.

Purpose of the Study:

  • To provide a framework for managing signs and symptoms in patients with metastatic functional neuroendocrine tumors.
  • To guide clinicians in recognizing and addressing paraneoplastic syndromes and tumor burden-related complaints.
  • To emphasize the importance of a comprehensive continuum of care in NET management.

Main Methods:

  • Review of current supportive care strategies for functional neuroendocrine tumors.
  • Integration of targeted therapies, surgical, and interventional radiologic techniques.
  • Consideration of individual patient variables for treatment prioritization.

Main Results:

  • Effective management of functional NETs requires addressing both paraneoplastic symptoms (e.g., flushing, diarrhea) and tumor burden symptoms (e.g., fatigue, pain).
  • Symptom improvement is linked to reducing elevated amino acid and peptide levels produced by NETs.
  • Minimizing treatment-related side effects (e.g., mucositis, myelosuppression) is a key component of supportive care.

Conclusions:

  • A comprehensive, early-stage care plan is essential for controlling presenting signs and symptoms in functional NETs.
  • Proactive management can significantly minimize disease- and treatment-related side effects.
  • This guide offers a framework for optimizing supportive care in metastatic functional neuroendocrine tumors.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...